Recall Weekly
Serious riskFDA DeviceClass I

Arrow pacing PSI kits recalled for possible sterility risk

Arrow International included local anesthetic drugs (lidocaine and bupivacaine) from a supplier with quality issues into several pacing procedure kits. The supplier's drugs had limited reports of ineffectiveness, and compromised sterility in injectable products could cause serious infection or other life-threatening complications.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if your facility received any Pacing PSI Kits with the affected lot numbers listed in the recall notice.
  2. Do not use affected kits; quarantine them and contact Arrow International or the FDA if you have questions.
  3. Contact your hospital's pharmacy, procurement, or medical device team to verify whether your inventory is affected.
Official notice ↗

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Description/REF: PACING PSI KIT: 6 FR/AI-06210-KS, PACING PSI KIT: 5 FR 2-L/AI-07155-KS, PACING PSI KIT: 5 FR 2L/ASK-07155-UPM
Sold in
Nationwide
Made for
All ages (under 100 years)

This recall covers 35 products — see all of them.

Details

Units affected
15,915
Illnesses reported
None reported
Manufactured in
3015 Carrington Mill Blvd, Morrisville, NC, United States
Classification
Class I
Recall number
Z-2366-2026

In the FDA's words

Description
Description/REF: PACING PSI KIT: 6 FR/AI-06210-KS, PACING PSI KIT: 5 FR 2-L/AI-07155-KS, PACING PSI KIT: 5 FR 2L/ASK-07155-UPM Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries. REF(Material)/UDI-DI/Lot(Batch): AI-06210-KS/10801902210217, 10801902211504/33F24G0127, 33F24H0302, 33F25E0321, 33F26A1322, 33F25B0008; AI-07155-KS/10801902210217, 10801902211481, 10801902197938/33F25B0056, 33F25C0574, 33F25D0190, 33F25D0688, 33F25E0387, 33F25E0467, 33F25E1140, 33F25E1211, 33F25G0708, 33F25H0269, 33F25H0319, 33F25H0357, 33F25J0606, 33F25L0085, 33F25L0313, 33F26A0018, 33F26A1258, 33F26A1305, 33F26B0256, 33F26B0731, 33F26B0938, 33F26C0063, 33F26C0271, 33F26C0537, 33F24D0003; ASK-07155-UPM/10801902210217, 10801902203172/33F25E0208, 33F25H0134, 33F25J0913, 33F25M0051, 33F23L0622 Distribution: US Nationwide distribution including in the states of VA, NY, UT, SC, LA, MN, PA, AZ, CA, MI, OH, FL, CT, KS, IL, TX, WI, GA, NC, MD, OR, AK, NH, IA, ND, OK, NM, AL, MA, KY, WA, AR, CO, IN, ME, TN, WY, NJ, SD, MS, MO, MT, DE, ID, NE, WV, RI, VT, NV, HI, DC, PR. Affected quantity: 15,915
Hazard
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.

35 products in this recall

Arrow kits with lidocaine and bupivacaine recalled for sterility risk

Arrow is recalling 35 kits and sets that contain lidocaine, bupivacaine, or 0.9% sodium chloride from a supplier that was itself recalled for quality issues. If the sterility of these water-based injectable drugs is compromised, it could lead to serious or life-threatening injuries. No injuries have been reported, and the products were distributed nationwide.

The agency lists each product separately. Check every one you might have.

Related topics

OtherSterilityMedical devicesSold nationwideMore from FDA Device